Ingo Schwaner

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Chronic Lymphocytic Leukemia

Metastatic Colorectal Cancer

Top Venues

Annals of hematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Ingo Schwaner, Thomas Kuhn, Christoph Losem, Thomas Wolff, Burkhard Otremba, Matthias Zaiss, Johannes Hülsenbeck, Kirsten Famulla, Thomas Nösslinger, Davide Rossi
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study. Annals of hematology 103 (6) (2024)
Ingo Schwaner, Thomas Kuhn, Christoph Losem, Thomas Wolff, Burkhard Otremba, Matthias Zaiss, Johannes Hülsenbeck, Kirsten Famulla, Thomas Nösslinger, Davide Rossi
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study. Annals of hematology (2024)
Ingo Schwaner, Thomas Kuhn, Christoph Losem, Thomas Wolff, Burkhard Otremba, Matthias Zaiss, Johannes Hülsenbeck, Kirsten Famulla, Thomas Nösslinger, Davide Rossi
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study. Annals of hematology 103 (6) (2024)
Ingo Schwaner, Thomas Kuhn, Christoph Losem, Thomas Wolff, Burkhard Otremba, Matthias Zaiss, Johannes Hülsenbeck, Kirsten Famulla, Thomas Nösslinger, Davide Rossi
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study. Annals of hematology 103 (6) (2024)
Ingo Schwaner, Thomas Kuhn, Christoph Losem, Thomas Wolff, Burkhard Otremba, Matthias Zaiss, Johannes Hülsenbeck, Kirsten Famulla, Thomas Nösslinger, Davide Rossi
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study. Annals of hematology 103 (6) (2024)
Hendrik Kröning, Thomas Göhler, Thomas Decker, Marc Grundeis, Georgi Kojouharoff, Jörg Lipke, Dieter Semsek, Enno Moorahrend, Annette Sauer, Harald-Robert Bruch, Rüdiger Liersch, Arnd Nusch, Ursula Vehling-Kaiser, Manfred Welslau, Ralf Grunewald, Hanns-Detlev Harich, Marcel Stephany, Jens Uhlig, Rebecca de Buhr, Melanie Frank, Cathrin Hogrefe, Norbert Marschner, Karin Potthoff, Frank Hartmann, Timo Reisländer, Ingo Schwaner
Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real-world data from the noninterventional TACTIC study in Germany. International journal of cancer (2023)
Sebastian Stinzing, Kathrin Heinrich, David Tougeron, Dominik Paul Modest, Ingo Schwaner, Jan Eucker, Rudolf Pihusch, Martina Stauch, Florian Kaiser, Christoph A Kahl, Meinolf Karthaus, Christian Müller, Christof Burkart, Anke C Reinacher-Schick, Stefan Kasper-Virchow, Ludwig Fischer von Weikersthal, Beate Krammer-Steiner, Gerald Wolfgang Prager, Gilles Manceau, Volker Heinemann
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF V600E -Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)